Nicole Mairon

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Stephen L. Hauser, Amit Bar‐Or, Gavin Giovannoni et al. · New England Journal of Medicine · 2016 · 2K citations · Full text

Life Sciences, Immunology, Neurology +17

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos et al. · New England Journal of Medicine · 2016 · 1.9K citations · Full text

Life Sciences, Immunology, Neurology +17

Monthly Oral Ibandronate Therapy in Postmenopausal Osteoporosis: 1-Year Results From the MOBILE Study

Paul D. Miller, Michael R. McClung, Liviu Macovei et al. · Journal of Bone and Mineral Research · 2005 · 334 citations

Medicine, Endocrinology, Bone Metabolism +9

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

Reginster Jy, S. Adámi, Péter L. Lakatos et al. · Annals of the Rheumatic Diseases · 2005 · 329 citations · Full text

Medicine, Endocrinology, Bone Metabolism +8

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study

Stuart L. Silverman, Arkadi Chines, David L. Kendler et al. · Osteoporosis International · 2011 · 164 citations

Medicine, Pharmacotherapy, Bone Metabolism +12